デフォルト表紙
市場調査レポート
商品コード
1459808

血液型タイピング市場:世界の産業分析、規模、シェア、成長、動向、予測、2023-2031年

Blood Group Typing Market (Product: Instruments, Consumables, and Services; and Technique: PCR-based, Microarray-based, and Assay-based, and Massively Parallel) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031


出版日
ページ情報
英文 234 Pages
納期
2~10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
血液型タイピング市場:世界の産業分析、規模、シェア、成長、動向、予測、2023-2031年
出版日: 2024年02月23日
発行: Transparency Market Research
ページ情報: 英文 234 Pages
納期: 2~10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

血液型タイピング市場- 調査範囲

TMRの血液型タイピング世界市場に関する調査レポートは、2023年から2031年までの予測期間における市場の指標に関する貴重な洞察を得るために、過去だけでなく現在の成長動向と機会についても調査しています。2023年を基準年、2031年を予測年として、2017年から2031年までの世界の血液型タイピング市場の収益と予測を提供します。また、2023年から2031年までの世界の血液型タイピング市場の複合年間成長率(CAGR %)も掲載しています。

本レポートは広範な調査を経て作成されました。1次調査では、主要オピニオンリーダー、業界リーダー、オピニオンメーカーへのインタビューを実施しました。2次調査では、主要企業の製品資料、年次報告書、プレスリリース、関連文書などを参照し、血液型タイピング市場を理解しました。

市場スナップショット
2022年の市場価値 26億米ドル
2031年の市場価値 55億米ドル
CAGR 8.8%

本レポートでは、世界の血液型タイピング市場の競合情勢について掘り下げています。世界の血液型タイピング市場で事業を展開する主要企業が特定され、これらの各企業がさまざまな属性でプロファイリングされています。企業概要、財務状況、最近の市場開拓、SWOTは、本レポートでプロファイリングされた世界の血液型タイピング市場のプレイヤーの属性です。

目次

第1章 序文

第2章 前提条件と調査手法

第3章 エグゼクティブサマリー:世界市場

第4章 市場概要

  • イントロダクション
  • 市場概要
  • 市場力学
  • 世界市場分析と予測、2017-2031年

第5章 主要洞察

  • パイプライン分析
  • 主要製品/ブランド分析
  • 主要M&A
  • COVID-19パンデミックの産業への影響

第6章 世界市場分析と予測:製品別

  • イントロダクションと定義
  • 主な調査結果/発展
  • 市場金額予測:製品別、2017-2031
    • 機器
      • 自動
      • 半自動
      • 手動
    • 消耗品
      • 試薬
      • 検査キット
      • 抗血清
      • その他
    • サービス
  • 市場魅力度:製品別

第7章 世界市場分析・予測:技術別

  • イントロダクションと定義
  • 主な調査結果/発展
  • 市場金額予測:技術別、2017年~2031年
    • PCRベース
    • マイクロアレイベース
    • アッセイベース
    • 超並列
  • 市場魅力度:技術別

第8章 世界市場分析・予測:検査別

  • イントロダクションと定義
  • 主な調査結果/発展
  • 市場金額予測:検査別, 2017-2031
    • 抗体スクリーニング
    • HLAタイピング
    • ABOマッチング検査
    • クロスマッチング検査
    • 抗原タイピング
  • 市場魅力度:検査別

第9章 世界市場分析・予測:エンドユーザー別

  • イントロダクションと定義
  • 主な調査結果/発展
  • 市場金額予測:エンドユーザー別、2017年~2031年
    • 病院
    • 臨床検査室
    • 血液銀行
    • その他
  • 市場魅力度:エンドユーザー別

第10章 世界市場分析・予測:地域別

  • 主な調査結果
  • 市場金額予測:地域別、2017年~2031年
    • 北米
    • 欧州
    • アジア太平洋
    • ラテンアメリカ
    • 中東・アフリカ
  • 市場魅力度:地域別

第11章 北米市場分析と予測

第12章 欧州市場分析と予測

第13章 アジア太平洋市場分析と予測

第14章 ラテンアメリカ市場分析と予測

第15章 中東・アフリカ市場分析と予測

第16章 競合情勢

  • 市場競合マトリックス(ティア別、企業規模別)
  • 市場シェア分析:企業別(2022年)
  • 企業プロファイル
    • Grifols, S.A.
    • Bio-Rad Laboratories, Inc.
    • Merck KGaA
    • Ortho Clinical Diagnostics
    • AliveDx
    • ABG Health Care GmbH
    • Immucor, Inc.
    • Danaher Corporation
    • Agena Bioscience, Inc.
    • Rapid Labs Ltd.
    • Novacyt Group
図表

List of Tables

  • Table 01: Global Blood Group Typing Market Size (US$ Mn) Forecast, by Product, 2017-2031
  • Table 02: Global Blood Group Typing Market Size (US$ Mn) Forecast, by Technique, 2017-2031
  • Table 03: Global Blood Group Typing Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 04: Global Blood Group Typing Market Size (US$ Mn) Forecast, by Test, 2017-2031
  • Table 05: Global Blood Group Typing Market Size (US$ Mn) Forecast, by Region, 2017-2031
  • Table 06: North America Blood Group Typing Market Size (US$ Mn) Forecast, by Country, 2017-2031
  • Table 07: North America Blood Group Typing Market Size (US$ Mn) Forecast, by Product, 2017-2031
  • Table 08: North America Blood Group Typing Market Size (US$ Mn) Forecast, by Technique, 2017-2031
  • Table 09: North America Blood Group Typing Market Size (US$ Mn) Forecast, by Test, 2017-2031
  • Table 10: North America Blood Group Typing Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 11: Europe Blood Group Typing Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 12: Europe Blood Group Typing Market Size (US$ Mn) Forecast, by Product, 2017-2031
  • Table 13: Europe Blood Group Typing Market Size (US$ Mn) Forecast, by Technique, 2017-2031
  • Table 14: Europe Blood Group Typing Market Size (US$ Mn) Forecast, by Test, 2017-2031
  • Table 15: Europe Blood Group Typing Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 16: Asia Pacific Blood Group Typing Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 17: Asia Pacific Blood Group Typing Market Size (US$ Mn) Forecast, by Product, 2017-2031
  • Table 18: Asia Pacific Blood Group Typing Market Size (US$ Mn) Forecast, by Technique, 2017-2031
  • Table 19: Asia Pacific Blood Group Typing Market Size (US$ Mn) Forecast, by Test, 2017-2031
  • Table 20: Asia Pacific Blood Group Typing Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 21: Latin America Blood Group Typing Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 22: Latin America Blood Group Typing Market Size (US$ Mn) Forecast, by Product, 2017-2031
  • Table 23: Latin America Blood Group Typing Market Size (US$ Mn) Forecast, by Technique, 2017-2031
  • Table 24: Latin America Blood Group Typing Market Size (US$ Mn) Forecast, by Test, 2017-2031
  • Table 25: Latin America Blood Group Typing Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 26: Middle East & Africa Blood Group Typing Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 27: Middle East & Africa Blood Group Typing Market Size (US$ Mn) Forecast, by Product, 2017-2031
  • Table 28: Middle East & Africa Blood Group Typing Market Size (US$ Mn) Forecast, by Technique, 2017-2031
  • Table 29: Middle East & Africa Blood Group Typing Market Size (US$ Mn) Forecast, by Test, 2017-2031
  • Table 30: Middle East & Africa Blood Group Typing Market Size (US$ Mn) Forecast, by End-user, 2017-2031

List of Figures

  • Figure 01: Global Blood Group Typing Market Size (US$ Mn) and Distribution (%), by Region, 2022-2031
  • Figure 02: Global Blood Group Typing Market Revenue (US$ Mn), by Product, 2022
  • Figure 03: Global Blood Group Typing Market Value Share, by Product, 2022
  • Figure 04: Global Blood Group Typing Market Revenue (US$ Mn), by Technique, 2022
  • Figure 05: Global Blood Group Typing Market Value Share, by Technique, 2022
  • Figure 06: Global Blood Group Typing Market Revenue (US$ Mn), by Test, 2022
  • Figure 07: Global Blood Group Typing Market Value Share, by Test, 2022
  • Figure 08: Global Blood Group Typing Market Revenue (US$ Mn), by End-user, 2022
  • Figure 09: Global Blood Group Typing Market Value Share, by End-user, 2022
  • Figure 10: Global Blood Group Typing Market Value Share, by Region, 2022
  • Figure 11: Global Blood Group Typing Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 12: Global Blood Group Typing Market Value Share Analysis, by Product, 2022-2031
  • Figure 13: Global Blood Group Typing Market Attractiveness Analysis, by Product, 2023-2031
  • Figure 14: Global Blood Group Typing Market Value Share Analysis, by Technique, 2022-2031
  • Figure 15: Global Blood Group Typing Market Attractiveness Analysis, by Technique, 2023-2031
  • Figure 16: Global Blood Group Typing Market Value Share Analysis, by Test, 2022-2031
  • Figure 17: Global Blood Group Typing Market Attractiveness Analysis, by Test, 2023-2031
  • Figure 18: Global Blood Group Typing Market Revenue (US$ Mn), by End-user, 2022
  • Figure 19: Global Blood Group Typing Market Value Share, by End-user, 2022
  • Figure 20: Global Blood Group Typing Market Value Share Analysis, by Region, 2022-2031
  • Figure 21: Global Blood Group Typing Market Attractiveness Analysis, by Region, 2023-2031
  • Figure 22: North America Blood Group Typing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 23: North America Blood Group Typing Market Attractiveness Analysis, by Country, 2023-2031
  • Figure 24: North America Blood Group Typing Market Value Share Analysis, by Country, 2022-2031
  • Figure 25: North America Blood Group Typing Market Value Share Analysis, by Product, 2022-2031
  • Figure 26: North America Blood Group Typing Market Value Share Analysis, by Technique, 2022-2031
  • Figure 27: North America Blood Group Typing Market Value Share Analysis, by Test, 2022-2031
  • Figure 28: North America Blood Group Typing Market Value Share Analysis, by End-user, 2022-2031
  • Figure 29: North America Blood Group Typing Market Value Share Analysis, by End-user, 2022-2031
  • Figure 30: North America Blood Group Typing Market Attractiveness Analysis, by Product, 2023-2031
  • Figure 31: North America Blood Group Typing Market Attractiveness Analysis, by Technique, 2023-2031
  • Figure 32: North America Blood Group Typing Market Attractiveness Analysis, by Test, 2023-2031
  • Figure 33: North America Blood Group Typing Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 34: Europe Blood Group Typing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 35: Europe Blood Group Typing Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 36: Europe Blood Group Typing Market Value Share Analysis, by Country/Sub-region, 2022-2031
  • Figure 37: Europe Blood Group Typing Market Value Share Analysis, by Product, 2022-2031
  • Figure 38: Europe Blood Group Typing Market Value Share Analysis, by Technique, 2022-2031
  • Figure 39: Europe Blood Group Typing Market Value Share Analysis, by Test, 2022-2031
  • Figure 40: Europe Blood Group Typing Market Value Share Analysis, by End-user, 2022-2031
  • Figure 41: Europe Blood Group Typing Market Value Share Analysis, by End-user, 2022-2031
  • Figure 42: Europe Blood Group Typing Market Attractiveness Analysis, by Product, 2023-2031
  • Figure 43: Europe Blood Group Typing Market Attractiveness Analysis, by Technique, 2023-2031
  • Figure 44: Europe Blood Group Typing Market Attractiveness Analysis, by Test, 2023-2031
  • Figure 45: Europe Blood Group Typing Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 46: Asia Pacific Blood Group Typing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 47: Asia Pacific Blood Group Typing Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 48: Asia Pacific Blood Group Typing Market Value Share Analysis, by Country/Sub-region, 2022-2031
  • Figure 50: Asia Pacific Blood Group Typing Market Value Share Analysis, by Product, 2022-2031
  • Figure 51: Asia Pacific Blood Group Typing Market Value Share Analysis, by Technique, 2022-2031
  • Figure 52: Asia Pacific Blood Group Typing Market Value Share Analysis, by Test, 2022-2031
  • Figure 53: Asia Pacific Blood Group Typing Market Value Share Analysis, by End-user, 2022-2031
  • Figure 54: Asia Pacific Blood Group Typing Market Value Share Analysis, by End-user, 2022-2031
  • Figure 55: Asia Pacific Blood Group Typing Market Attractiveness Analysis, by Product, 2023-2031
  • Figure 56: Asia Pacific Blood Group Typing Market Attractiveness Analysis, by Technique, 2023-2031
  • Figure 57: Asia Pacific Blood Group Typing Market Attractiveness Analysis, by Test, 2023-2031
  • Figure 68: Asia Pacific Blood Group Typing Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 59: Latin America Blood Group Typing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 60: Latin America Blood Group Typing Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 61: Latin America Blood Group Typing Market Value Share Analysis, by Country/Sub-region, 2022-2031
  • Figure 62: Latin America Blood Group Typing Market Value Share Analysis, by Product, 2022-2031
  • Figure 63: Latin America Blood Group Typing Market Value Share Analysis, by Technique, 2022-2031
  • Figure 64: Latin America Blood Group Typing Market Value Share Analysis, by Test, 2022-2031
  • Figure 65: Latin America Blood Group Typing Market Value Share Analysis, by End-user, 2022-2031
  • Figure 66: Latin America Blood Group Typing Market Value Share Analysis, by End-user, 2022-2031
  • Figure 67: Latin America Blood Group Typing Market Attractiveness Analysis, by Product, 2023-2031
  • Figure 68: Latin America Blood Group Typing Market Attractiveness Analysis, by Technique, 2023-2031
  • Figure 69: Latin America Blood Group Typing Market Attractiveness Analysis, by Test, 2023-2031
  • Figure 70: Latin America Blood Group Typing Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 71: Middle East & Africa Blood Group Typing Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 72: Middle East & Africa Blood Group Typing Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 73: Middle East & Africa Blood Group Typing Market Value Share Analysis, by Country/Sub-region, 2022-2031
  • Figure 74: Middle East & Africa Blood Group Typing Market Value Share Analysis, by Product, 2022-2031
  • Figure 75: Middle East & Africa Blood Group Typing Market Value Share Analysis, by Technique, 2022-2031
  • Figure 76: Middle East & Africa Blood Group Typing Market Value Share Analysis, by Test, 2022-2031
  • Figure 77: Middle East & Africa Blood Group Typing Market Value Share Analysis, by End-user, 2022-2031
  • Figure 78: Middle East & Africa Blood Group Typing Market Value Share Analysis, by End-user, 2022-2031
  • Figure 79: Middle East & Africa Blood Group Typing Market Attractiveness Analysis, by Product, 2023-2031
  • Figure 80: Middle East & Africa Blood Group Typing Market Attractiveness Analysis, by Technique, 2023-2031
  • Figure 81: Middle East & Africa Blood Group Typing Market Attractiveness Analysis, by Test, 2023-2031
  • Figure 82: Middle East & Africa Blood Group Typing Market Attractiveness Analysis, by End-user, 2023-2031
目次
Product Code: TMRGL32999

Blood Group Typing Market - Scope of Report

TMR's report on the global blood group typing market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global blood group typing market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global blood group typing market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the blood group typing market.

Market Snapshot
Market Value in 2022US$ 2.6 Bn
Market Value in 2031US$ 5.5 Bn
CAGR8.8%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global blood group typing market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global blood group typing market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global blood group typing market.

The report delves into the competitive landscape of the global blood group typing market. Key players operating in the global blood group typing market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global blood group typing market profiled in this report.

Key Questions Answered in Global blood group typing Market Report:

  • What is the sales/revenue generated by blood group typing across all regions during the forecast period?
  • What are the opportunities in the global blood group typing market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Blood Group Typing Market - Research Objectives and Research Approach

The comprehensive report on the global blood group typing market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global blood group typing market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global blood group typing market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Blood Group Typing Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Product Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Blood Group Typing Market Analysis and Forecast, 2017-2031

5. Key Insights

  • 5.1. Pipeline Analysis
  • 5.2. Key Product/Brand Analysis
  • 5.3. Key Mergers & Acquisitions
  • 5.4. COVID-19 Pandemic Impact on Industry

6. Global Blood Group Typing Market Analysis and Forecast, by Product

  • 6.1. Introduction and Definitions
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Product, 2017-2031
    • 6.3.1. Instruments
      • 6.3.1.1. Automated
      • 6.3.1.2. Semi-automated
      • 6.3.1.3. Manual
    • 6.3.2. Consumables
      • 6.3.2.1. Reagents
      • 6.3.2.2. Test Kits
      • 6.3.2.3. Antisera
      • 6.3.2.4. Others
    • 6.3.3. Services
  • 6.4. Market Attractiveness, by Product

7. Global Blood Group Typing Market Analysis and Forecast, by Technique

  • 7.1. Introduction and Definitions
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by Technique, 2017-2031
    • 7.3.1. PCR-based
    • 7.3.2. Microarray-based
    • 7.3.3. Assay-based
    • 7.3.4. Massively Parallel
    • 7.3.5. 7.4 Market Attractiveness, by Technique

8. Global Blood Group Typing Market Analysis and Forecast, by Test

  • 8.1. Introduction and Definitions
  • 8.2. Key Findings/Developments
  • 8.3. Market Value Forecast, by Test, 2017-2031
    • 8.3.1. Antibody Screening
    • 8.3.2. HLA Typing
    • 8.3.3. ABO Matching Test
    • 8.3.4. Cross Matching Test
    • 8.3.5. Antigen Typing
  • 8.4. Market Attractiveness, by Test

9. Global Blood Group Typing Market Analysis and Forecast, by End-user

  • 9.1. Introduction and Definitions
  • 9.2. Key Findings/Developments
  • 9.3. Market Value Forecast, by End-user, 2017-2031
    • 9.3.1. Hospitals
    • 9.3.2. Clinical Laboratories
    • 9.3.3. Blood Banks
    • 9.3.4. Others
  • 9.4. Market Attractiveness, by End-user

10. Global Blood Group Typing Market Analysis and Forecast, by Region

  • 10.1. Key Findings
  • 10.2. Market Value Forecast, by Region, 2017-2031
    • 10.2.1. North America
    • 10.2.2. Europe
    • 10.2.3. Asia Pacific
    • 10.2.4. Latin America
    • 10.2.5. Middle East & Africa
  • 10.3. Market Attractiveness, by Region

11. North America Blood Group Typing Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Product, 2017-2031
    • 11.2.1. Instruments
      • 11.2.1.1. Automated
      • 11.2.1.2. Semi-automated
      • 11.2.1.3. Manual
    • 11.2.2. Consumables
      • 11.2.2.1. Reagents
      • 11.2.2.2. Test Kits
      • 11.2.2.3. Antisera
      • 11.2.2.4. Others
    • 11.2.3. Services
  • 11.3. Market Attractiveness, by Product
  • 11.4. Market Value Forecast, by Technique, 2017-2031
    • 11.4.1. PCR-based
    • 11.4.2. Microarray-based
    • 11.4.3. Assay-based
    • 11.4.4. Massively Parallel
  • 11.5. Market Attractiveness, by Technique
  • 11.6. Market Value Forecast, by Test, 2017-2031
    • 11.6.1. Antibody Screening
    • 11.6.2. HLA Typing
    • 11.6.3. ABO Matching Test
    • 11.6.4. Cross Matching Test
    • 11.6.5. Antigen Typing
  • 11.7. Market Attractiveness, by Test
  • 11.8. Market Value Forecast, by End-user, 2017-2031
    • 11.8.1. Hospitals
    • 11.8.2. Clinical Laboratories
    • 11.8.3. Blood Banks
    • 11.8.4. Others
  • 11.9. Market Attractiveness, by End-user
  • 11.10. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 11.10.1. U.S.
    • 11.10.2. Canada
  • 11.11. Market Attractiveness Analysis
    • 11.11.1. By Product
    • 11.11.2. By Technique
    • 11.11.3. By Test
    • 11.11.4. By End-user
    • 11.11.5. By Country

12. Europe Blood Group Typing Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Product, 2017-2031
    • 12.2.1. Instruments
      • 12.2.1.1. Automated
      • 12.2.1.2. Semi-automated
      • 12.2.1.3. Manual
    • 12.2.2. Consumables
      • 12.2.2.1. Reagents
      • 12.2.2.2. Test Kits
      • 12.2.2.3. Antisera
      • 12.2.2.4. Others
    • 12.2.3. Services
  • 12.3. Market Attractiveness, by Product
  • 12.4. Market Value Forecast, by Technique, 2017-2031
    • 12.4.1. PCR-based
    • 12.4.2. Microarray-based
    • 12.4.3. Assay-based
    • 12.4.4. Massively Parallel
  • 12.5. Market Attractiveness, by Technique
  • 12.6. Market Value Forecast, by Test, 2017-2031
    • 12.6.1. Antibody Screening
    • 12.6.2. HLA Typing
    • 12.6.3. ABO Matching Test
    • 12.6.4. Cross Matching Test
    • 12.6.5. Antigen Typing
  • 12.7. Market Attractiveness, by Test
  • 12.8. Market Value Forecast, by End-user, 2017-2031
    • 12.8.1. Hospitals
    • 12.8.2. Clinical Laboratories
    • 12.8.3. Blood Banks
    • 12.8.4. Others
  • 12.9. Market Attractiveness, by End-user
  • 12.10. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 12.10.1. Germany
    • 12.10.2. U.K.
    • 12.10.3. France
    • 12.10.4. Italy
    • 12.10.5. Spain
    • 12.10.6. Rest of Europe
  • 12.11. Market Attractiveness Analysis
    • 12.11.1. By Product
    • 12.11.2. By Technique
    • 12.11.3. By Test
    • 12.11.4. By End-user
    • 12.11.5. By Country/Sub-region

13. Asia Pacific Blood Group Typing Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Product, 2017-2031
    • 13.2.1. Instruments
      • 13.2.1.1. Automated
      • 13.2.1.2. Semi-automated
      • 13.2.1.3. Manual
    • 13.2.2. Consumables
      • 13.2.2.1. Reagents
      • 13.2.2.2. Test Kits
      • 13.2.2.3. Antisera
      • 13.2.2.4. Others
    • 13.2.3. Services
  • 13.3. Market Attractiveness, by Product
  • 13.4. Market Value Forecast, by Technique, 2017-2031
    • 13.4.1. PCR-based
    • 13.4.2. Microarray-based
    • 13.4.3. Assay-based
    • 13.4.4. Massively Parallel
  • 13.5. Market Attractiveness, by Technique
  • 13.6. Market Value Forecast, by Test, 2017-2031
    • 13.6.1. Antibody Screening
    • 13.6.2. HLA Typing
    • 13.6.3. ABO Matching Test
    • 13.6.4. Cross Matching Test
    • 13.6.5. Antigen Typing
  • 13.7. Market Attractiveness, by Test
  • 13.8. Market Value Forecast, by End-user, 2017-2031
    • 13.8.1. Hospitals
    • 13.8.2. Clinical Laboratories
    • 13.8.3. Blood Banks
    • 13.8.4. Others
  • 13.9. Market Attractiveness, by End-user
  • 13.10. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 13.10.1. China
    • 13.10.2. Japan
    • 13.10.3. India
    • 13.10.4. Australia & New Zealand
    • 13.10.5. Rest of Asia Pacific
  • 13.11. Market Attractiveness Analysis
    • 13.11.1. By Product
    • 13.11.2. By Technique
    • 13.11.3. By Test
    • 13.11.4. By End-user
    • 13.11.5. By Country/Sub-region

14. Latin America Blood Group Typing Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Product, 2017-2031
    • 14.2.1. Instruments
      • 14.2.1.1. Automated
      • 14.2.1.2. Semi-automated
      • 14.2.1.3. Manual
    • 14.2.2. Consumables
      • 14.2.2.1. Reagents
      • 14.2.2.2. Test Kits
      • 14.2.2.3. Antisera
      • 14.2.2.4. Others
    • 14.2.3. Services
  • 14.3. Market Attractiveness, by Product
  • 14.4. Market Value Forecast, by Technique, 2017-2031
    • 14.4.1. PCR-based
    • 14.4.2. Microarray-based
    • 14.4.3. Assay-based
    • 14.4.4. Massively Parallel
  • 14.5. Market Attractiveness, by Technique
  • 14.6. Market Value Forecast, by Test, 2017-2031
    • 14.6.1. Antibody Screening
    • 14.6.2. HLA Typing
    • 14.6.3. ABO Matching Test
    • 14.6.4. Cross Matching Test
    • 14.6.5. Antigen Typing
  • 14.7. Market Attractiveness, by Test
  • 14.8. Market Value Forecast, by End-user, 2017-2031
    • 14.8.1. Hospitals
    • 14.8.2. Clinical Laboratories
    • 14.8.3. Blood Banks
    • 14.8.4. Others
  • 14.9. Market Attractiveness, by End-user
  • 14.10. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 14.10.1. Brazil
    • 14.10.2. Mexico
    • 14.10.3. Rest of Latin America
  • 14.11. Market Attractiveness Analysis
    • 14.11.1. By Product
    • 14.11.2. By Technique
    • 14.11.3. By Test
    • 14.11.4. By End-user
    • 14.11.5. By Country/Sub-region

15. Middle East & Africa Blood Group Typing Market Analysis and Forecast

  • 15.1. Introduction
    • 15.1.1. Key Findings
  • 15.2. Market Value Forecast, by Product, 2017-2031
    • 15.2.1. Instruments
      • 15.2.1.1. Automated
      • 15.2.1.2. Semi-automated
      • 15.2.1.3. Manual
    • 15.2.2. Consumables
      • 15.2.2.1. Reagents
      • 15.2.2.2. Test Kits
      • 15.2.2.3. Antisera
      • 15.2.2.4. Others
    • 15.2.3. Services
  • 15.3. Market Attractiveness, by Product
  • 15.4. Market Value Forecast, by Technique, 2017-2031
    • 15.4.1. PCR-based
    • 15.4.2. Microarray-based
    • 15.4.3. Assay-based
    • 15.4.4. Massively Parallel
  • 15.5. Market Attractiveness, by Technique
  • 15.6. Market Value Forecast, by Test, 2017-2031
    • 15.6.1. Antibody Screening
    • 15.6.2. HLA Typing
    • 15.6.3. ABO Matching Test
    • 15.6.4. Cross Matching Test
    • 15.6.5. Antigen Typing
  • 15.7. Market Attractiveness, by Test
  • 15.8. Market Value Forecast, by End-user, 2017-2031
    • 15.8.1. Hospitals
    • 15.8.2. Clinical Laboratories
    • 15.8.3. Blood Banks
    • 15.8.4. Others
  • 15.9. Market Attractiveness, by End-user
  • 15.10. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 15.10.1. GCC Countries
    • 15.10.2. South Africa
    • 15.10.3. Rest of Middle East & Africa
  • 15.11. Market Attractiveness Analysis
    • 15.11.1. By Product
    • 15.11.2. By Technique
    • 15.11.3. By Test
    • 15.11.4. By End-user
    • 15.11.5. By Country/Sub-region

16. Competition Landscape

  • 16.1. Market Player - Competition Matrix (By Tier and Size of Companies)
  • 16.2. Market Share Analysis, by Company (2022)
  • 16.3. Company Profiles
    • 16.3.1. Grifols, S.A.
      • 16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.1.2. Product Portfolio
      • 16.3.1.3. Financial Overview
      • 16.3.1.4. SWOT Analysis
      • 16.3.1.5. Strategic Overview
    • 16.3.2. Bio-Rad Laboratories, Inc.
      • 16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.2.2. Product Portfolio
      • 16.3.2.3. Financial Overview
      • 16.3.2.4. SWOT Analysis
      • 16.3.2.5. Strategic Overview
    • 16.3.3. Merck KGaA
      • 16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.3.2. Product Portfolio
      • 16.3.3.3. Financial Overview
      • 16.3.3.4. SWOT Analysis
      • 16.3.3.5. Strategic Overview
    • 16.3.4. Ortho Clinical Diagnostics
      • 16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.4.2. Product Portfolio
      • 16.3.4.3. Financial Overview
      • 16.3.4.4. SWOT Analysis
      • 16.3.4.5. Strategic Overview
    • 16.3.5. AliveDx
      • 16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.5.2. Product Portfolio
      • 16.3.5.3. Financial Overview
      • 16.3.5.4. SWOT Analysis
      • 16.3.5.5. Strategic Overview
    • 16.3.6. ABG Health Care GmbH
      • 16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.6.2. Product Portfolio
      • 16.3.6.3. Financial Overview
      • 16.3.6.4. SWOT Analysis
      • 16.3.6.5. Strategic Overview
    • 16.3.7. Immucor, Inc.
      • 16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.7.2. Product Portfolio
      • 16.3.7.3. Financial Overview
      • 16.3.7.4. SWOT Analysis
      • 16.3.7.5. Strategic Overview
    • 16.3.8. Danaher Corporation
      • 16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.8.2. Product Portfolio
      • 16.3.8.3. Financial Overview
      • 16.3.8.4. SWOT Analysis
      • 16.3.8.5. Strategic Overview
    • 16.3.9. Agena Bioscience, Inc.
      • 16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.9.2. Product Portfolio
      • 16.3.9.3. Financial Overview
      • 16.3.9.4. SWOT Analysis
      • 16.3.9.5. Strategic Overview
    • 16.3.10. Rapid Labs Ltd.
      • 16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.10.2. Product Portfolio
      • 16.3.10.3. Financial Overview
      • 16.3.10.4. SWOT Analysis
      • 16.3.10.5. Strategic Overview
    • 16.3.11. Novacyt Group
      • 16.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.11.2. Product Portfolio
      • 16.3.11.3. Financial Overview
      • 16.3.11.4. SWOT Analysis
      • 16.3.11.5. Strategic Overview